Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04240938
Other study ID # Minia2020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2017
Est. completion date December 30, 2019

Study information

Verified date January 2020
Source Minia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with lacrimal dacryocystocele were chosen for the study. Dacryocystorhinostomy were done for them after their evaluation.


Description:

Evaluation for lacrimal passage in the included patients using syringing, probing and dye disappearance test. Dacryocystorhinostomy were done for all patients and followed up for at least 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 30, 2019
Est. primary completion date November 21, 2019
Accepts healthy volunteers No
Gender All
Age group 19 Years to 75 Years
Eligibility Inclusion Criteria:

- Lacrimal sac mucocele

- Acquired type

Exclusion Criteria:

- No previous lacrimal sac surgery

- Suspected lacrimal sac malignancy

Study Design


Intervention

Procedure:
Dacryocystorhinostomy
Anastomosis between lacrimal sac and nasal cavity

Locations

Country Name City State
Egypt Faculty of Medicine Minya Minia

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patency of the lacrimal passage Disappearance of the watering of the eye reported by the patients and by fluorescein disappearance test 2 weeks
Primary Disappearance of lacrimal sac swelling No evident swelling in the medial side of the eye 1 month